Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells

被引:34
作者
Caudle, RM
Karai, L
Mena, N
Cooper, BY
Mannes, AJ
Perez, FM
Iadarola, MJ
Olah, Z
机构
[1] Univ Florida, Coll Dent, Dept Oral & Maxillofacial Surg, Gainesville, FL 32610 USA
[2] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA
[3] Natl Inst Dent & Craniofacial Res, Pain & Neurosensory Mech Branch, NIH, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
vanilloid; nociceptors; neuroablation; resiniferatoxin; capsaicin; TRPV1;
D O I
10.1016/S0161-813X(03)00146-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Resiniferatoxin (RTX), a potent analog of capsaicin, was evaluated electrophysiologically in dorsal root ganglion (DRG) cells and cell lines ectopically expressing the vanilloid receptor type 1 (VR1) to determine if cell phenotype influenced RTXs neurotoxic properties. Furthermore, capsaicin and heat activation of VR1 were evaluated in these cells to determine if cellular damage was unique to RTX activation of the receptors. RTX application to DRG cells identified as type 1, 2 or 5, cell types known to express VR1, induced large inward currents. RTX did not induce currents in DRG cells that do not express the receptor (type 4 cells). In cell lines ectopically expressing VR1, RTX-induced similar currents. RTX produced no effect in non-transfected cells. After exposure to RTX both DRG cells and transfected cells failed to respond to subsequent applications of the agonist. In addition, whole cell capacitance was reduced up to 70%. The decrease in capacitance was associated with the loss of plasma membrane, as determined by confocal microscopy. Cell phenotype, other than VR1 expression, did not influence the response to RTX. Interestingly, capsaicin and heat activation of vanilloid receptors also decreased cell capacitance, but the loss of membrane was not as great as with RTX and responses to these stimuli were not lost after the initial exposure. The loss of cell membrane required elevated intracellular levels of Ca2+ From these data it was concluded that the loss of cell membrane was dependent on the presence of both VR1 and intracellular Ca2+ accumulation, but not on cell phenotype. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:895 / 908
页数:14
相关论文
共 38 条
[1]   FACILITATION OF THE HUMAN NOCICEPTIVE REFLEX BY STIMULATION OF ALPHA-BETA-FIBERS IN A SECONDARY HYPERALGESIC AREA SUSTAINED BY NOCICEPTIVE INPUT FROM THE PRIMARY HYPERALGESIC AREA [J].
ANDERSEN, OK ;
GRACELY, RH ;
ARENDTNIELSEN, L .
ACTA PHYSIOLOGICA SCANDINAVICA, 1995, 155 (01) :87-97
[2]   Recent advances in understanding of vanilloid receptors: A therapeutic target for treatment of pain and inflammation in skin [J].
Biro, T ;
Acs, G ;
Acs, P ;
Modarres, S ;
Blumberg, PM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, 1997, :56-60
[3]   Impaired nociception and pain sensation in mice lacking the capsaicin receptor [J].
Caterina, MJ ;
Leffler, A ;
Malmberg, AB ;
Martin, WJ ;
Trafton, J ;
Petersen-Zeitz, KR ;
Koltzenburg, M ;
Basbaum, AI ;
Julius, D .
SCIENCE, 2000, 288 (5464) :306-313
[4]   The capsaicin receptor: a heat-activated ion channel in the pain pathway [J].
Caterina, MJ ;
Schumacher, MA ;
Tominaga, M ;
Rosen, TA ;
Levine, JD ;
Julius, D .
NATURE, 1997, 389 (6653) :816-824
[5]  
Chandrasekaran B, 1999, J SCI IND RES INDIA, V58, P1
[6]   The tissue distribution and functional characterization of human VR1 [J].
Cortright, DN ;
Crandall, M ;
Sanchez, JF ;
Zou, T ;
Krause, JE ;
White, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (05) :1183-1189
[7]   Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia [J].
Davis, JB ;
Gray, J ;
Gunthorpe, MJ ;
Hatcher, JP ;
Davey, PT ;
Overend, P ;
Harries, MH ;
Latcham, J ;
Clapham, C ;
Atkinson, K ;
Hughes, SA ;
Rance, K ;
Grau, E ;
Harper, AJ ;
Pugh, PL ;
Rogers, DC ;
Bingham, S ;
Randall, A ;
Sheardown, SA .
NATURE, 2000, 405 (6783) :183-187
[8]   Sensory changes in the territory of the lingual and inferior alveolar nerves following lower third molar extraction [J].
Eliav, E ;
Gracely, RH .
PAIN, 1998, 77 (02) :191-199
[9]  
Faddis BT, 1997, J NEUROSCI, V17, P951
[10]  
Ferguson SSG, 2001, PHARMACOL REV, V53, P1